Microenvironment-driven resistance to B-Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts

The incidence of malignant melanoma is rapidly increasing and current medicine is offering only limited options for treatment of the advanced disease. For B-Raf mutated melanomas, treatment with mutation-specific drug inhibitors may be used. Unfortunately, tumors frequently acquire resistance to the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Med
Main Authors: Kodet, Ondřej, Dvořánková, Barbora, Bendlová, Běla, Sýkorová, Vlasta, Krajsová, Ivana, Štork, Jiří, Kučera, Jan, Szabo, Pavol, Strnad, Hynek, Kolář, Michal, Vlček, Čestmír, Smetana, Karel, Lacina, Lukáš
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2018
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846633/
https://ncbi.nlm.nih.gov/pubmed/29393387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3448
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares